Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galera Therapeutics Inc (NQ: GRTX )

0.1450 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Galera Therapeutics Inc

< Previous 1 2 3 4 5 6 7 Next >
Gold Edges Lower; Alibaba Posts Upbeat Results
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Thursday. The Dow traded up 0.44% to 35,277.94 while the NASDAQ rose 0.29% to 13,761.56. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Down 1%; Disney Profit Tops Expectations
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.78% to 35,396.50 while the NASDAQ rose 0.84% to 13,837.91. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Disney Explores Strategic Shift Away from Traditional TV, FTX Management & Creditors Clash, Alibaba's Q1 Earnings: Today's Top Stories
Financial Times 
Via Benzinga
Analyst Ratings for Galera Therapeutics
Via Benzinga
Where Galera Therapeutics Stands With Analysts
Via Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
Via Benzinga
Dow Jumps Over 300 Points; US Inflation Rate Rises To 3.2%
U.S. stocks traded higher this morning, following the release of inflation data on Thursday. Following the market opening Thursday, the Dow traded up 0.95% to 35,456.19 while the NASDAQ rose 1.03% to... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
What Is Going on With Applied UV (AUVI) Stock Today?
Applied UV (AUVI) stock is on the move Thursday as investors react to the disinfectant company getting $4 million in orders. 
Via InvestorPlace
Why Is Galera Therapeutics Stock Sinking Today?
The FDA issued a Complete Response Letter (CRL) to Galera Therapeutics Inc's (NASDAQ: GRTX) New Drug Application (NDA) for avasopasem manganese (avasopasem) for radiotherapy-induced severe oral... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is Amyris (AMRS) Stock Down 67% Today?
Amyris (AMRS) stock is falling on Thursday after the company filed for Chapter 11 bankruptcy protection to facilitate a restructuring. 
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
Why Is Galera Therapeutics (GRTX) Stock Down 83% Today?
Galera Therapeutics (GRTX) stock is falling hard on Thursday following a drug rejection by the FDA and plans to cut its workforce! 
Via InvestorPlace
Exposures Product Safety
Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
From Galera Therapeutics
Via GlobeNewswire
Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Gainers Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares surged 83.5% to $0.1648 in pre-market trading after falling over 25% on Monday. The company recently announced its plans to reduce the... 
Via Benzinga
Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting
From Galera Therapeutics
Via GlobeNewswire
Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer
Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapy 
From Galera Therapeutics
Via GlobeNewswire
Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates
From Galera Therapeutics
Via GlobeNewswire
Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Galera Therapeutics
Via GlobeNewswire
Galera Expands Commercial Leadership Team
From Galera Therapeutics
Via GlobeNewswire
Galera to Present One-Year Reductions in Cisplatin-Related Chronic Kidney Disease Data from ROMAN Trial at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
From Galera Therapeutics
Via GlobeNewswire
Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology
From Galera Therapeutics
Via GlobeNewswire
Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
From Galera Therapeutics
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants
From Galera Therapeutics
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.